Skip to content

A Longitudinal Observational Study Investigating the Association Between Amyloid Pathology and Electroencephalographic Findings

A Longitudinal Observational Study Investigating the Association Between Amyloid Pathology and Electroencephalographic Findings - Amyloid-EEG Longitudinal Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060451
Enrollment
300
Registered
2026-01-23
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are considered, based on the treating physician&#39

Interventions

None listed

Sponsors

the University of Osaka
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are considered, based on the treating physician's clinical judgment, to be potentially eligible for anti-amyloid beta antibody therapy

Exclusion criteria

Exclusion criteria: Patients who are judged by the treating physician to be inappropriate for participation in this study, based on the patient's clinical condition and the purpose of the study.

Design outcomes

Primary

MeasureTime frame
To exploratorily assess the association between electroencephalographic characteristics and clinical information obtained from routine clinical practice related to anti-amyloid beta antibody therapy.

Countries

Japan

Contacts

Public ContactMasahiro Hata

the University of Osaka Department of Psychiatry

mhata@psy.med.osaka-u.ac.jp0668793051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026